PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för LY294002. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

9 hits

Bibliografisk träff 2015-01-01

PI3-Kinase Inhibitor LY294002 Repressed the Expression of Thrombin-Activatable Fibrinolysis Inhibitor in Human Hepatoma HepG2 Cells.

Masuda Y, Yazawa J, Makino Y, Takada K.

Biol Pharm Bull · research support, non-u.s. gov't; journal article · DOI 10.1248/bpb.b15-00295

Bibliografisk träff 2014-12-07

Inhibition of the PI3K/Akt pathway by Ly294002 does not prevent establishment of persistent Junín virus infection in Vero cells.

Linero FN, Fernández Bell-Fano PM, Cuervo E, Castilla V, Scolaro LA.

Arch Virol · research support, non-u.s. gov't; journal article; case-report · DOI 10.1007/s00705-014-2298-6

Bibliografisk träff 2014-10-27

LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.

Zhou Y, Zhu LB, Peng AF, Wang TF, Long XH, Gao S, Zhou RP, Liu ZL.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2014.2787

Bibliografisk träff 2014-07-31

PI3K inhibitors LY294002 and IC87114 reduce inflammation in carrageenan-induced paw oedema and down-regulate inflammatory gene expression in activated macrophages.

Eräsalo H, Laavola M, Hämäläinen M, Leppänen T, Nieminen R, Moilanen E.

Basic Clin Pharmacol Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1111/bcpt.12284

Bibliografisk träff 2014-04-04

Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapy.

Saiyin W, Wang D, Li L, Zhu L, Liu B, Sheng L, Li Y, Zhu B, Mao L, Li G, Zhu X.

Mol Pharm · research support, non-u.s. gov't; journal article · DOI 10.1021/mp5000423

Bibliografisk träff 2010-04-01

Pharmacological inhibition of phosphoinositide 3 and TOR kinases improves survival of Drosophila melanogaster.

Moskalev AA, Shaposhnikov MV.

Rejuvenation Res · research support, non-u.s. gov't; journal article · DOI 10.1089/rej.2009.0903

Bibliografisk träff 2008-06-28

The phosphatidylinositol 3-kinase inhibitor LY 294002 inhibits GlyT1-mediated glycine uptake.

Wu ZL, O'Kane TM, Connors TJ, Marino MJ, Schaffhauser H.

Brain Res · journal article · DOI 10.1016/j.brainres.2008.06.078

Bibliografisk träff 2001-09-01

LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes.

Shoba LN, Newman M, Liu W, Lowe WL.

Endocrinology · research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1210/endo.142.9.8394

Bibliografisk träff 1999-09-01

P13-kinase inhibition induces dauer formation, thermotolerance and longevity in C. elegans.

Babar P, Adamson C, Walker GA, Walker DW, Lithgow GJ.

Neurobiol Aging · research support, non-u.s. gov't; journal article · DOI 10.1016/s0197-4580(99)00094-9